BeOne Medicines (BEIGF) Exchange Rate Effect (2015 - 2026)

BeOne Medicines (BEIGF) has reported Exchange Rate Effect for 12 consecutive years, with $19.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Exchange Rate Effect fell 15.51% year-over-year to $19.8 million in Q2 2026; TTM through Jun 2026 was $72.2 million, a 1910.66% increase from a year earlier, with the FY2025 full-year figure at $60.0 million, up 216.09% from the prior year.
• Exchange Rate Effect was $19.8 million for Q2 2026 at BeOne Medicines, up from $19.3 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $64.5 million in Q4 2022 and troughed at -$80.2 million in Q2 2022.
• A 5-year average of -$1.7 million and a median of $9.5 million in 2022 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect sank 4247.95% in 2022 and soared 5299.62% in 2024, its largest moves.
• Over 5 years, Exchange Rate Effect stood at $64.5 million in 2022, then slumped by 34.52% to $42.3 million in 2023, then plunged by 222.35% to -$51.7 million in 2024, then jumped by 144.79% to $23.2 million in 2025, then dropped by 14.36% to $19.8 million in 2026.
• The last three Exchange Rate Effect figures came in at $19.8 million (Q2 2026), $19.3 million (Q1 2026), and $23.2 million (Q4 2025), per Business Quant data.